Novastan argatroban small molecule inhibitor of thrombin data

TXB announced that beneficial effects of argatroban were demonstrated in two Phase II trials presented at the meeting of the American College of Cardiology

Read the full 241 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE